BACKGROUND:Stent implantation for isolated stenosis of the proximal left anterior descending coronary artery (LAD) with preserved left ventricular function has been found to have a better clinical and angiographic outcome at one year than balloon angioplasty (PTCA). OBJECTIVE: To establish whether those results are maintained at five year follow up. METHODS: Patients were followed at least every six months. For those who died during follow up, data were obtained from medical records. MAIN OUTCOME MEASURES: Freedom from death, non-fatal myocardial infarction, cerebrovascular accident, and repeated target lesion revascularisation. Secondary end points were revascularisation in a remote region and freedom from angina. RESULTS: Follow up was complete in all patients. At five years, the primary end point was reached more often by patients randomised to stent implantation than to PTCA (80% v 53%; odds ratio (OR) 0.29 (95% confidence interval (CI) 0.13 to 0.69); p = 0.0034). In the PTCA group, 35% of patients underwent target lesion revascularisation v 15% in the stent group (OR 0.33, 95% CI 0.13 to 0.80; p = 0.014). There was a trend towards increased mortality in the PTCA group than in the stent group (17% v 7%; OR 0.36, 95% CI 0.10 to 1.21; p = 0.098). No significant differences were found between PTCA and stent groups for non-fatal myocardial infarction (8% v 5%; OR 0.58, 95% CI 0.13 to 2.54; p = 0.46) or cerebrovascular accident (2% v 0%). CONCLUSIONS: In patients with isolated stenosis of the proximal LAD, a five year clinical follow up confirmed a better outcome in those treated with stenting than with PTCA.
RCT Entities:
BACKGROUND: Stent implantation for isolated stenosis of the proximal left anterior descending coronary artery (LAD) with preserved left ventricular function has been found to have a better clinical and angiographic outcome at one year than balloon angioplasty (PTCA). OBJECTIVE: To establish whether those results are maintained at five year follow up. METHODS:Patients were followed at least every six months. For those who died during follow up, data were obtained from medical records. MAIN OUTCOME MEASURES: Freedom from death, non-fatal myocardial infarction, cerebrovascular accident, and repeated target lesion revascularisation. Secondary end points were revascularisation in a remote region and freedom from angina. RESULTS: Follow up was complete in all patients. At five years, the primary end point was reached more often by patients randomised to stent implantation than to PTCA (80% v 53%; odds ratio (OR) 0.29 (95% confidence interval (CI) 0.13 to 0.69); p = 0.0034). In the PTCA group, 35% of patients underwent target lesion revascularisation v 15% in the stent group (OR 0.33, 95% CI 0.13 to 0.80; p = 0.014). There was a trend towards increased mortality in the PTCA group than in the stent group (17% v 7%; OR 0.36, 95% CI 0.10 to 1.21; p = 0.098). No significant differences were found between PTCA and stent groups for non-fatal myocardial infarction (8% v 5%; OR 0.58, 95% CI 0.13 to 2.54; p = 0.46) or cerebrovascular accident (2% v 0%). CONCLUSIONS: In patients with isolated stenosis of the proximal LAD, a five year clinical follow up confirmed a better outcome in those treated with stenting than with PTCA.
Authors: R Choussat; C Klersy; A J Black; I Bossi; J P Laurent; C Jordan; G Guagliumi; J Fajadet; J Marco Journal: Am J Cardiol Date: 2001-07-01 Impact factor: 2.778
Authors: D van Dijk; A P Nierich; E W Jansen; H M Nathoe; W J Suyker; J C Diephuis; W J van Boven; C Borst; E Buskens; D E Grobbee; E O Robles De Medina; P P de Jaegere Journal: Circulation Date: 2001-10-09 Impact factor: 29.690
Authors: A Betriu; M Masotti; A Serra; J Alonso; F Fernández-Avilés; F Gimeno; T Colman; J Zueco; J L Delcan; E García; J Calabuig Journal: J Am Coll Cardiol Date: 1999-11-01 Impact factor: 24.094
Authors: S R Mehta; S Yusuf; R J Peters; M E Bertrand; B S Lewis; M K Natarajan; K Malmberg; H Rupprecht; F Zhao; S Chrolavicius; I Copland; K A Fox Journal: Lancet Date: 2001-08-18 Impact factor: 79.321
Authors: A B Greenbaum; R M Califf; R H Jones; L H Gardner; H R Phillips; M H Sketch; R S Stack; J A Puma Journal: Am J Cardiol Date: 2000-12-15 Impact factor: 2.778
Authors: F Kiemeneij; P W Serruys; C Macaya; W Rutsch; G Heyndrickx; P Albertsson; J Fajadet; V Legrand; P Materne; J Belardi; U Sigwart; A Colombo; J J Goy; C M Disco; M A Morel Journal: J Am Coll Cardiol Date: 2001-05 Impact factor: 24.094
Authors: David J Moliterno; Steven J Yakubov; Peter M DiBattiste; Howard C Herrmann; Gregg W Stone; Carlos Macaya; Franz-Josef Neumann; Diego Ardissino; Jean-Pierre Bassand; Lynn Borzi; Alan C Yeung; Katherine A Harris; Laura A Demopoulos; Eric J Topol Journal: Lancet Date: 2002-08-03 Impact factor: 79.321
Authors: Patrick W J C Serruys; Pim de Feyter; Carlos Macaya; Norbert Kokott; Jacques Puel; Matthias Vrolix; Angelo Branzi; Marcelo C Bertolami; Graham Jackson; Bradley Strauss; Bernhard Meier Journal: JAMA Date: 2002-06-26 Impact factor: 56.272
Authors: Marie-Claude Morice; Patrick W Serruys; J Eduardo Sousa; Jean Fajadet; Ernesto Ban Hayashi; Marco Perin; Antonio Colombo; G Schuler; Paul Barragan; Giulio Guagliumi; Ferenc Molnàr; Robert Falotico Journal: N Engl J Med Date: 2002-06-06 Impact factor: 91.245
Authors: Mohammad Alidoosti; Mojtaba Salarifar; Ali Mohammad Haji Zeinali; Seyed Ebrahim Kassaian; Maria Raissi Dehkordi Journal: BMC Cardiovasc Disord Date: 2007-03-04 Impact factor: 2.298